Department of Microbiology, College of Medicine and Medical Research Institute, Chungbuk National University, 12 Gaeshin-Dong Heungduk-Ku, Cheongju 361-763, Republic of Korea.
Biochem Biophys Res Commun. 2011 Oct 28;414(3):569-74. doi: 10.1016/j.bbrc.2011.09.119. Epub 2011 Oct 1.
Influenza A virus infection stimulates a wide range of virus-supportive or antiviral mechanisms in host cells. p21-Activated kinase 1 (PAK1) is a serine/threonine kinase that regulates a number of fundamental cellular processes and has been implicated in the modulation of virus replication. Here, we investigated the role of PAK1 activation during influenza A virus infection and found that virus propagation corresponded to stimulated PAK1 phosphorylation. Moreover, transfection of the active form of PAK1 (PAK1-T423E) in A549 cells induced higher viral titers (∼10-fold differences) compared to that in the control vector or inactive PAK1 (PAK1-K299R)-transfected cells. PAK1-specific siRNA knockdown also resulted in 10-100-fold reductions in virus yields compared to that in the control siRNA-treatment (p<0.05). We further showed that treatment with PAK18, a PAK1 peptide inhibitor, resulted in marked suppression of both ERK 1/2 phosphorylation and infectious virus production, which was comparable to that by U0126, a specific MEK/ERK inhibitor. These results provide evidence for the importance of PAK1 activation during influenza virus infection and its association with ERK in regulating virus replication. The present study also implicates PAK1 as a potential therapeutic target for managing influenza virus infections.
甲型流感病毒感染会刺激宿主细胞内一系列支持病毒或抗病毒的机制。p21 激活激酶 1(PAK1)是一种丝氨酸/苏氨酸激酶,调节许多基本的细胞过程,并与病毒复制的调节有关。在这里,我们研究了 PAK1 在甲型流感病毒感染过程中的激活作用,发现病毒繁殖与 PAK1 磷酸化的刺激有关。此外,在 A549 细胞中转染 PAK1 的活性形式(PAK1-T423E)会导致更高的病毒滴度(差异约为 10 倍),而与对照载体或无活性 PAK1(PAK1-K299R)转染细胞相比。PAK1 特异性 siRNA 敲低也会导致病毒产量与对照 siRNA 处理相比减少 10-100 倍(p<0.05)。我们进一步表明,PAK1 肽抑制剂 PAK18 的处理导致 ERK 1/2 磷酸化和感染性病毒产生的明显抑制,与特定的 MEK/ERK 抑制剂 U0126 相当。这些结果为 PAK1 在流感病毒感染过程中的激活及其与 ERK 调节病毒复制的相关性提供了证据。本研究还表明 PAK1 是治疗流感病毒感染的潜在治疗靶点。